Fundraising FoxNextGen Jane
Oakland, US · Founded 2014 · Delaware corporation · 1 known investors
Find your way into NextGen Jane
Sign up to see every warm intro you have to NextGen Jane
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NextGen Jane team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NextGen Jane runs a longitudinal molecular study of women's menstruation, using an at-home organic cotton tampon collection kit that members mail in to derive genomic insights from uterine samples. The company aims to improve diagnostics and treatment for gynecological conditions such as endometriosis and other menstrual and reproductive health issues.
Founders & leadership
NextGen Jane was founded in 2014 by Stephen Gire and Ridhi Tariyal.
Investors · 1
How we know: Material Impact's portfolio page · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$19.5M disclosed across 4 rounds · 2016–2023
▶$7MraisedOct 2023 · 7 investors · Other Health CareRule 506(b)
- Stephen GireExecutive Officer, Director
- Deborah KilpatrickDirector
- Ridhi TariyalExecutive Officer, Director
- Adam SharkawyDirector
- Offering amount
- $7.8M
- Amount sold
- $7M
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedJun 2022 · 2 investors · Other Health CareRule 506(b)
- STEPHEN GIREExecutive Officer, Director
- RIDHI TARIYALExecutive Officer, Director
- DEBORAH KILPATRICKDirector
- ADAM SHARKAWYDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.7MraisedApr 2019 · 14 investors · Other Health CareRule 506(b)
- Adam SharkawyDirector
- Stephen GireExecutive Officer, Director
- Ridhi TariyalExecutive Officer, Director
- Deborah KilpatrickDirector
- Offering amount
- $8.7M
- Amount sold
- $8.7M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$2.2MraisedMar 2016 · 7 investors · Other Health CareRule 506(b)
- Stephen GireDirector
- Ridhi TariyalExecutive Officer, Director
- Offering amount
- $2.4M
- Amount sold
- $2.2M
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
Companies working in the same space as NextGen Jane.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $267.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does NextGen Jane do?
- NextGen Jane runs a longitudinal molecular study of women's menstruation, using an at-home organic cotton tampon collection kit that members mail in to derive genomic insights from uterine samples. The company aims to improve diagnostics and treatment for gynecological conditions such as endometriosis and other menstrual and reproductive health issues.
- Who founded NextGen Jane?
- NextGen Jane was founded by Stephen Gire, Ridhi Tariyal in 2014.
- Who are NextGen Jane's investors?
- NextGen Jane's investors include Material Impact.
- How much funding has NextGen Jane raised?
- NextGen Jane has disclosed $19.5M raised across 4 rounds.
- Where is NextGen Jane headquartered?
- NextGen Jane is headquartered in Oakland, US.